Form 4: RenaissanceRe Director Bushnell Receives Restricted Stock Grant

Sentiment:

SEC Form 4 Filing


Director David C. Bushnell of RenaissanceRe Holdings Ltd. reports the acquisition of 738 shares of common stock on March 1, 2024, as part of a restricted stock grant.

Summary

  • David C. Bushnell, a director of RenaissanceRe Holdings Ltd., acquired 738 shares of common stock on March 1, 2024.
  • The acquisition was a grant of restricted shares under the company's 2016 Long Term Incentive Plan.
  • The shares will vest in three equal annual installments starting on March 1, 2025.
  • Following the transaction, Bushnell beneficially owns 20,011 shares of RenaissanceRe common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral to slightly positive event.

Positives

  • The grant of restricted stock aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted shares will vest over the next three years, incentivizing the director to contribute to the company's long-term success.

Industry Context

Grants of restricted stock are a common practice in the insurance and reinsurance industry to align the interests of directors and executives with those of shareholders.

Comparison to Industry Standards

  • Many companies in the reinsurance sector, such as Everest Re and Arch Capital Group, utilize restricted stock grants as part of their executive compensation packages.
  • The vesting schedules are typically between three to five years, which is in line with RenaissanceRe's three-year vesting period.

Stakeholder Impact

  • Shareholders may view the restricted stock grant positively as it aligns the director's interests with the company's long-term performance.
  • Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

DateDescription
03/01/2024Date of transaction: Grant of restricted shares.
03/01/2025First vesting date for the restricted shares.
03/05/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.